Disc Medicine has received a complete response letter (CRL) from the US Food and Drug Administration (FDA) concerning its new drug application (NDA) for bitopertin for erythropoietic protoporphyria ...
GRAND RAPIDS, Mich. (WOOD) – Low back pain and disc issues are some of the most common conditions affecting people of all ages, often leading to chronic discomfort and mobility limitations. Our Back ...